Trial Outcomes & Findings for Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty (NCT NCT03859024)

NCT ID: NCT03859024

Last Updated: 2024-09-19

Results Overview

Self-report via pain score on the Numerical Rating Scale (NRS) for pain, an 11-point scale for patient self-reporting of pain. A rating of 0 equates to no pain, 1-3 equates to mild pain, 4-6 equates to moderate pain, and 7-10 equates to severe pain. Assessment will occur at clinic visit, at pre-op visit, in pre-op holding before surgery, per anesthesia protocol after surgery in recovery and discharge unit, and at postoperative visit

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

48 participants

Primary outcome timeframe

3 weeks

Results posted on

2024-09-19

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Protocol
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Ibuprofen 800 mg: ibuprofen tablet
Enhanced Recovery Protocol
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Gabapentin: gabapentin tablet celebrex: Celebrex tablet Bupivacaine: bupivacaine injection Ibuprofen 800 mg: ibuprofen tablet Dexamethasone: Dexamethasone injection
Overall Study
STARTED
23
25
Overall Study
COMPLETED
23
24
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Ibuprofen 800 mg: ibuprofen tablet
Enhanced Recovery Protocol
n=25 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Gabapentin: gabapentin tablet celebrex: Celebrex tablet Bupivacaine: bupivacaine injection Ibuprofen 800 mg: ibuprofen tablet Dexamethasone: Dexamethasone injection
Total
n=48 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=23 Participants
0 Participants
n=25 Participants
0 Participants
n=48 Participants
Age, Categorical
Between 18 and 65 years
20 Participants
n=23 Participants
21 Participants
n=25 Participants
41 Participants
n=48 Participants
Age, Categorical
>=65 years
3 Participants
n=23 Participants
4 Participants
n=25 Participants
7 Participants
n=48 Participants
Age, Continuous
50 years
n=23 Participants
50 years
n=25 Participants
50 years
n=48 Participants
Sex: Female, Male
Female
0 Participants
n=23 Participants
0 Participants
n=25 Participants
0 Participants
n=48 Participants
Sex: Female, Male
Male
23 Participants
n=23 Participants
25 Participants
n=25 Participants
48 Participants
n=48 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
23 participants
n=23 Participants
25 participants
n=25 Participants
48 participants
n=48 Participants

PRIMARY outcome

Timeframe: 3 weeks

Self-report via pain score on the Numerical Rating Scale (NRS) for pain, an 11-point scale for patient self-reporting of pain. A rating of 0 equates to no pain, 1-3 equates to mild pain, 4-6 equates to moderate pain, and 7-10 equates to severe pain. Assessment will occur at clinic visit, at pre-op visit, in pre-op holding before surgery, per anesthesia protocol after surgery in recovery and discharge unit, and at postoperative visit

Outcome measures

Outcome measures
Measure
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Ibuprofen 800 mg: ibuprofen tablet
Enhanced Recovery Protocol
n=24 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Gabapentin: gabapentin tablet celebrex: Celebrex tablet Bupivacaine: bupivacaine injection Ibuprofen 800 mg: ibuprofen tablet Dexamethasone: Dexamethasone injection
Participant Pain Control: Numerical Rating Scale (NRS)
1.2 score on a scale
Interval 0.0 to 10.0
.625 score on a scale
Interval 0.0 to 10.0

PRIMARY outcome

Timeframe: 3 weeks

Amount of opioid medication used, based on return pill count at postoperative visit.

Outcome measures

Outcome measures
Measure
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Ibuprofen 800 mg: ibuprofen tablet
Enhanced Recovery Protocol
n=24 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed. Oxycodone: oxycodone tablet Acetaminophen: acetaminophen tablet Gabapentin: gabapentin tablet celebrex: Celebrex tablet Bupivacaine: bupivacaine injection Ibuprofen 800 mg: ibuprofen tablet Dexamethasone: Dexamethasone injection
Opioid Medication Use
5.14 pill count
Interval 0.0 to 14.0
4.96 pill count
Interval 0.0 to 14.0

Adverse Events

Standard Protocol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Enhanced Recovery Protocol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Adam Baumgarten

University of Alabama at Birmingham

Phone: 205-996-6769

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place